Gilead Sciences (GILD) Free Cash Flow (2009 - 2026)

Gilead Sciences (GILD) has reported Free Cash Flow for 18 consecutive years, with $2.4 billion the latest figure, recorded in Q1 2026.

• Free Cash Flow for Q1 2026 came in at $2.4 billion, up 46.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.2 billion (up 3.92% YoY), and the FY2025 annual result was $9.5 billion, down 8.24% from the prior year.
• Free Cash Flow was $2.4 billion for Q1 2026 at Gilead Sciences, down from $3.1 billion in the prior quarter.
• Over five years, Free Cash Flow peaked at $4.2 billion in Q3 2024 and troughed at $720.0 million in Q2 2025.
• Average Free Cash Flow over 5 years is $2.2 billion, with a median of $2.1 billion recorded in 2024.
• The widest YoY moves for Free Cash Flow: up 155.24% in 2024, down 45.66% in 2024.
• Over 5 years, Free Cash Flow stood at $2.4 billion in 2022, then dropped by 18.11% to $2.0 billion in 2023, then surged by 44.73% to $2.8 billion in 2024, then climbed by 10.4% to $3.1 billion in 2025, then fell by 22.26% to $2.4 billion in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $2.4 billion in Q1 2026, $3.1 billion in Q4 2025, and $4.0 billion in Q3 2025.